Explore evidence

5.35 %The overall prevalence of HIV infection in this study was 5.35%.

NigeriaVIH/sidapublished 2021Journal of medical virologyPubMeddocument of 11 observations

Nigeria has the fourth largest burden of HIV globally.

NigeriaVIH/sidapublished 2022JMIR public health and surveillancePubMeddocument of 5 observations

7.5 %The North-Central zone of Nigeria has an HIV prevalence rate of 7.5%.

NigeriaVIH/sidapublished 2021Nigerian journal of clinical practicePubMeddocument of 7 observations

28.2 %Among 168 people living with HIV (PLHIV) studied, 28.2% had good knowledge of mother-to-child transmission (MTCT) of HIV.

NigeriaVIH/sidapublished 2021The Pan African medical journalPubMeddocument of 5 observations

2.17 AORRespondents living with HIV had higher odds for sexual violence (AOR: 2.17; 95% CI: 1.55–3.05; p < 0.001).

NigeriaVIH/sidaobserved 2021published 2022BMC public healthPubMeddocument of 12 observations

Women with primary Toxoplasma gondii and HIV coinfection had lower CD4+ T-cell count than those with toxoplasmosis monoinfection.

NigeriaToxoplasma gondii infection · VIH/sidapublished 2020Malawi medical journal : the journal of Medical Association of MalawiPubMeddocument of 8 observations

100 %Minor PI resistance-associated mutation K20I was identified in 100% of subtype G/UG HIV-1 isolates.

NigeriaVIH/sidapublished 2020PloS onePubMeddocument of 11 observations

98 %246 (98.0%) of the participants were retained in care.

NigeriaVIH/sidapublished 2021PloS onePubMeddocument of 10 observations

9.9 adjusted_odds_ratioChildren living with HIV were 10 times more likely to have been told their status if their caregivers believed that disclosure had benefits, with an adjusted odds ratio of 9.9 (95% CI = 3.2–15.1).

NigeriaVIH/sidapublished 2020BMC public healthPubMeddocument of 5 observations

23.7 %Less than a quarter of adolescents and young adults (AYA) in Nigeria had ever tested for HIV, specifically 23.7%.

NigeriaVIH/sidaobserved 2017published 2020PloS onePubMeddocument of 4 observations

10 clientsBetween January 2023 to December 2023, 10 clients on antiretroviral drugs in rural areas in Delta, Ekiti and Osun states accessed Drug Information Services.

NigeriaVIH/sidaobserved January 2023 to December 2023published 2025Currents in pharmacy teaching & learningPubMeddocument of 9 observations

66.5 %The total attitude score towards HIV PEP among doctors was 66.5% with a standard deviation of 12.2%.

NigeriaVIH/sidapublished 2020West African journal of medicinePubMeddocument of 6 observations

5.1 %C. krusei was isolated in 5.1% of the patients.

NigeriaC. krusei · oral candidiasis · VIH/sidapublished 2026BMC infectious diseasesPubMeddocument of 11 observations

100 %In the ART Surge, treatment initiation rate was 100%.

NigeriaVIH/sidapublished 2021PloS onePubMeddocument of 13 observations

0 %Using malaria microscopy, the prevalence of malaria parasitaemia was 0% in HIV-negative persons.

Nigeriapaludisme · VIH/sidaobserved 2018–2019published 2024BMC infectious diseasesPubMeddocument of 15 observations

-6.3 per_weekIn a clinic in Nigeria, antiretroviral therapy initiations per week decreased by 6.3 points after the beginning of the pandemic.

NigeriaVIH/sidapublished 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 4 observations

Maternal HIV infection is associated with small for gestational age.

NigeriaVIH/sidapublished 2019West African journal of medicinePubMeddocument of 4 observations

98.6 %Among HIV-positive pregnant women in Kaduna State, 98.6% had a positive attitude towards antiretroviral therapy.

NigeriaVIH/sidapublished 2025Scientific reportsPubMeddocument of 4 observations

66.7 %Among patients with ≥2 viral load measurements on tenofovir, lamivudine, and dolutegravir (TLD), viral resuppression to ≤50 copies/ml at follow-up occurred in 66.7% of those with initial low-level viremia (51–199 copies/ml).

NigeriaVIH/sidapublished 2024AIDS (London, England)PubMeddocument of 8 observations

1.44 %HIV prevalence among participants aged ≥18 months in the Nigeria AIDS Indicator and Impact Survey (NAIIS) 2018 was 1.44%.

NigeriaVIH/sidaobserved 2018published 2022PLOS global public healtheurope_pmcdocument of 10 observations

38 %38% of the ART clients investigated were last receiving three- to five-month multi-month dispensing, and 10% of those on three- to five-month multi-month dispensing had interrupted treatment.

NigeriaVIH/sidaobserved 2000-2020published 2021BMC public healthPubMeddocument of 12 observations

7.7 %The rate of TB and HIV coinfection was 7.7%.

Nigeriatuberculose · VIH/sidapublished 2020Nigerian journal of clinical practicePubMeddocument of 4 observations

16.1 %HBsAg prevalence among 310 HIV-positive individuals in Southwestern Nigeria was 16.1% (50/310).

Nigeriahépatite B · VIH/sidaobserved June 2017 to August 2017published 2021Virology journalPubMeddocument of 6 observations

99 %Among participants with viral load results (n = 199), 99% were virally suppressed (<1000 copies/ml) at 12 months.

NigeriaVIH/sidaobserved 12 monthspublished 2023PloS onePubMeddocument of 12 observations

64.3 μg/LHIV-positive pregnant women had significantly lower mean serum selenium concentration compared with HIV-negative pregnant women (64.3 ± 19.6 μg/L vs. 100.1 ± 30.9 μg/L).

NigeriaVIH/sidapublished 2023Annals of African medicinePubMeddocument of 5 observations